|2013 classification criteria for systemic sclerosis: an American College of Rheumatology/European League against Rheumatism collaborative initiative|
F Van Den Hoogen, D Khanna, J Fransen, SR Johnson, M Baron, ...
Arthritis & Rheumatism 65 (11), 2737-2747, 2013
|Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader …|
N Nishimoto, J Hashimoto, N Miyasaka, K Yamamoto, S Kawai, ...
Annals of the rheumatic diseases 66 (9), 1162-1167, 2007
|Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database|
AJ Tyndall, B Bannert, M Vonk, P Airň, F Cozzi, PE Carreira, DF Bancel, ...
Annals of the rheumatic diseases 69 (10), 1809-1815, 2010
|Systemic sclerosis: demographic, clinical, and serologic features and survival in 1,012 Italian patients|
C Ferri, G Valentini, F Cozzi, M Sebastiani, C Michelassi, G La Montagna, ...
Medicine 81 (2), 139-153, 2002
|EULAR recommendations for the treatment of systemic sclerosis: a report from the EULAR Scleroderma Trials and Research group (EUSTAR)|
O Kowal-Bielecka, R Landewé, J Avouac, S Chwiesko, I Miniati, L Czirjak, ...
Annals of the rheumatic diseases 68 (5), 620-628, 2009
|Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research …|
K Visser, W Katchamart, E Loza, JA Martinez-Lopez, C Salliot, J Trudeau, ...
Annals of the rheumatic diseases 68 (7), 1086-1093, 2009
|European multicentre study to define disease activity criteria for systemic sclerosis. II. Identification of disease activity variables and development of preliminary activity …|
G Valentini, A Della Rossa, S Bombardieri, W Bencivelli, AJ Silman, ...
Annals of the rheumatic diseases 60 (6), 592-598, 2001
|Update of EULAR recommendations for the treatment of systemic sclerosis|
O Kowal-Bielecka, J Fransen, J Avouac, M Becker, A Kulak, Y Allanore, ...
Annals of the Rheumatic Diseases 76 (8), 1327-1339, 2017
|Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L)|
GS Alarcón, G McGwin, AM Bertoli, BJ Fessler, J Calvo-Alén, HM Bastian, ...
Annals of the rheumatic diseases 66 (9), 1168-1172, 2007
|Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group|
J Avouac, J Fransen, UA Walker, V Riccieri, V Smith, C Muller, I Miniati, ...
Annals of the rheumatic diseases 70 (3), 476-481, 2011
|Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group|
S Jordan, JHW Distler, B Maurer, D Huscher, JM Van Laar, Y Allanore, ...
Annals of the rheumatic diseases 74 (6), 1188-1194, 2015
|Disease remission and sustained halting of radiographic progression with combination etanercept and methotrexate in patients with rheumatoid arthritis|
D Van der Heijde, L Klareskog, R Landewe, GAW Bruyn, A Cantagrel, ...
Arthritis & Rheumatism: Official Journal of the American College of …, 2007
|Different antibody patterns and different prognoses in patients with scleroderma with various extent of skin sclerosis.|
M Giordano, G Valentini, S Migliaresi, U Picillo, M Vatti
The Journal of rheumatology 13 (5), 911-916, 1986
|Influence of testosterone therapy on clinical and immunological features of autoimmune diseases associated with Klinefelter’s syndrome|
A Bizzarro, G Valentini, GDI MARTINO, A DaPonte, A DE BELLIS, ...
The Journal of Clinical Endocrinology & Metabolism 64 (1), 32-36, 1987
|Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database|
FMP Meier, KW Frommer, R Dinser, UA Walker, L Czirjak, CP Denton, ...
Annals of the rheumatic diseases 71 (8), 1355-1360, 2012
|Genome-wide scan identifies TNIP1, PSORS1C1, and RHOB as novel risk loci for systemic sclerosis|
Y Allanore, M Saad, P Dieudé, J Avouac, JHW Distler, P Amouyel, ...
PLoS genetics 7 (7), 2011
|The challenge of early systemic sclerosis for the EULAR Scleroderma Trial and Research group (EUSTAR) community. It is time to cut the Gordian knot and develop a prevention or …|
M Matucci-Cerinic, Y Allanore, L Czirják, A Tyndall, U Müller-Ladner, ...
Annals of the rheumatic diseases 68 (9), 1377-1380, 2009
|Blood coagulation, fibrinolysis, and markers of endothelial dysfunction in systemic sclerosis|
MM Cerinic, G Valentini, GG Sorano, S D'angelo, G Cuomo, L Fenu, ...
Seminars in arthritis and rheumatism 32 (5), 285-295, 2003
|Cyclophosphamide pulse regimen in the treatment of alveolitis in systemic sclerosis.|
R Giacomelli, G Valentini, F Salsano, P Cipriani, P Sambo, ML Conforti, ...
The Journal of Rheumatology 29 (4), 731-736, 2002
|Good clinical response, remission, and predictors of remission in rheumatoid arthritis patients treated with tumor necrosis factor-alpha blockers: the GISEA study.|
L Mancarella, F Bobbio-Pallavicini, F Ceccarelli, PC Falappone, ...
The Journal of rheumatology 34 (8), 1670-1673, 2007